Who
Mark Christopher Capone
Director
Company insider
Files Form 4 as: Director, Mesa Laboratories; Director, Sera Prognostics; Director, DermTech; President & C.E.O., Myriad Genetics.
In numbers
- Trades disclosed
- 209
- Buys
- 2
- Sells
- 16
- Bought
- $411K
- Sold
- $31.0M
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 16 Feb 2006
- Last trade
- 9 Sep 2026
- Last filed
- 11 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Sep 2026filed 11 Sep 2026 | MLAB Mesa Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —2,423 at $0.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | MLAB Mesa Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —2,423 at $0.00 | filing |
| 15 Aug 2026filed 17 Aug 2026 | MLAB Mesa LaboratoriesLife-science tools | SEC FORM 4 Code M | —2,784 at $0.00 | filing |
| 15 Aug 2026filed 17 Aug 2026 | MLAB Mesa Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —2,784 at $0.00 | filing |
| 15 Aug 2026filed 17 Aug 2026 | MLAB Mesa Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —2,784 at $0.00 | filing |
| 15 Aug 2026filed 17 Aug 2026 | MLAB Mesa LaboratoriesLife-science tools | SEC FORM 4 Code M | —2,784 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —42,404 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —1,975 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —62,766 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —62,766 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —3,037 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | SERA Sera Prognosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —3,037 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —42,404 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | SERA Sera PrognosticsDiagnostics & Labs | SEC FORM 4 Code A | —1,975 at $0.00 | filing |
| 10 Mar 2026filed 10 Mar 2026 | MLAB Mesa LaboratoriesLife-science tools | SEC FORM 4 Bought | $99K1,301 at $76.35 | filing |
| 10 Mar 2026filed 10 Mar 2026 | MLAB Mesa LaboratoriesLife-science tools | SEC FORM 4 Bought | $99K1,301 at $76.35 | filing |
| 15 Aug 2025filed 18 Aug 2025 | MLAB Mesa Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,404 at $0.00 | filing |
| 15 Aug 2025filed 18 Aug 2025 | MLAB Mesa Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —2,784 at $0.00 | filing |
| 15 Aug 2025filed 18 Aug 2025 | MLAB Mesa LaboratoriesLife-science tools | SEC FORM 4 Code M | —1,404 at $0.00 | filing |
| 15 Aug 2024filed 19 Aug 2024 | MLAB Mesa Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —724 at $0.00 | filing |
News
Mesa Laboratories To Cut 40 Jobs, Plan $9.3 Mln Cost SavingsMLAB · rttnews.com · 13 Oct 2026
0 headlines in the last 90 days name Mark Christopher Capone; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.